Takuma Yoshitaka, Shota Iwadou, Miyatake Hirokazu, Uematsu Shuji, Okamoto Ryouichi, Araki Yasuyuki, Takabatake Hiroyuki, Morimoto Youichi, Yamamoto Hiroshi
Department of Internal Medicine, Hiroshima City Hospital, Japan.
Department of Gastroenterology, Kurashiki Central Hospital, Japan.
Intern Med. 2018 Feb 15;57(4):457-468. doi: 10.2169/internalmedicine.9064-17. Epub 2017 Nov 20.
Objective The purpose of this study was to construct nomograms for the disease-free survival (DFS) and overall survival (OS) of post-radiofrequency ablation (RFA) patients with hepatocellular carcinoma (HCC). Furthermore, we compared the prognostic predictive ability of these nomograms for estimating per-patient outcomes with that of traditional staging systems. Methods We retrospectively enrolled 298 patients in the training set and 272 patients in the validation set who underwent RFA for HCC. The nomograms for the DFS and OS were constructed from the training set using the multivariate Cox proportional hazards model. The discriminatory accuracy of the models was compared with traditional staging systems by analyzing the Harrell's C-index. Results The DFS nomogram was developed based on the tumor size, tumor number, aspartate aminotransferase (AST), albumin, age, and α-fetoprotein. The OS nomogram was developed based on the tumor size, the model for end-stage liver disease, AST, and albumin. Our DFS and OS nomograms had good calibration and discriminatory abilities in the training set, with C-indexes of 0.640 and 0.692, respectively, that were greater than those of traditional staging systems. The C-indexes of our DFS and OS nomograms were also greater than those of traditional staging systems in the validation set, with C-indexes of 0.614 and 0.657, respectively. RFA patients were stratified into low- and high-risk groups based on the median nomogram scores. High-risk patients receiving surgical resection (SR) were associated with a better DFS and OS than those undergoing RFA. However, the DFS and OS were similar between the low-risk RFA and SR groups. Conclusion We constructed reliable and useful nomograms that accurately predict the DFS and OS after RFA for early-stage HCC patients. These graphical tools are easy to use and will assist physicians during the therapeutic decision-making process.
目的 本研究旨在构建肝细胞癌(HCC)射频消融(RFA)术后患者无病生存(DFS)和总生存(OS)的列线图。此外,我们比较了这些列线图与传统分期系统对患者预后预测的能力。方法 我们回顾性纳入了298例训练集患者和272例验证集患者,这些患者均因HCC接受了RFA治疗。使用多变量Cox比例风险模型从训练集中构建DFS和OS的列线图。通过分析Harrell's C指数,将模型的辨别准确性与传统分期系统进行比较。结果 DFS列线图基于肿瘤大小、肿瘤数量、天冬氨酸转氨酶(AST)、白蛋白、年龄和甲胎蛋白构建。OS列线图基于肿瘤大小、终末期肝病模型、AST和白蛋白构建。我们的DFS和OS列线图在训练集中具有良好的校准和辨别能力,C指数分别为0.640和0.692,均高于传统分期系统。在验证集中,我们的DFS和OS列线图的C指数也高于传统分期系统,分别为0.614和0.657。根据列线图评分中位数,将RFA患者分为低风险和高风险组。接受手术切除(SR)的高风险患者与接受RFA的患者相比,DFS和OS更好。然而,低风险RFA组和SR组的DFS和OS相似。结论 我们构建了可靠且有用的列线图,可准确预测早期HCC患者RFA术后的DFS和OS。这些图形工具易于使用,将有助于医生在治疗决策过程中做出判断。